Yes, adults can get RSV (respiratory syncytial virus). In fact, most adults have had an RSV infection at least once in their lives. This seasonal virus is so widespread that almost all of us have had ...
The winter respiratory virus season is still in full swing, with Illinois under a “high” alert level from the Centers for Disease Control and Prevention. Among the viruses circulating most are ...
Vaccine uptake may not be much better during the 2024–25 respiratory virus season. Fewer than two in five (38%) eligible recipients plan to get an RSV vaccine, according to a survey conducted in ...
Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...
As many patients and their families are learning, infection with respiratory syncytial virus (RSV) is not something to trifle with. Annually, rates of hospitalization and deaths from RSV in the U.S.
Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER ...
Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers for Disease Control and Prevention. Is it RSV, COVID or the flu? RSV ...
Though there are now respiratory syncytial virus (RSV) vaccines approved by the FDA and recommended by the CDC for certain high-risk adults, what happens when someone ends up with severe illness from ...
This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...
AJMC®: How has limited awareness of respiratory syncytial virus (RSV) infection risk impacted vaccination rates of adults in the long term–care setting? FELTNER: There is a widespread misconception ...
GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...
GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...